Mirum Pharmaceuticals, Inc. (MIRM) financial statements (2022 and earlier)

Company profile

Business Address 950 TOWER LANE, SUITE 1050
FOSTER CITY, CA 94404
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments156,541231,820116,660
Cash and cash equivalents31,340142,08611,970
Short-term investments125,20189,734104,690
Receivables3,267  
Inventory, net of allowances, customer advances and progress billings1,513  
Inventory1,513  
Other undisclosed current assets5,2714,5302,703
Total current assets:166,592236,350119,363
Noncurrent Assets
Operating lease, right-of-use asset1,5691,9492,361
Property, plant and equipment9811,2931,372
Long-term investments and receivables4,983 23,292
Long-term investments4,983 23,292
Intangible assets, net (including goodwill)18,740  
Intangible assets, net (excluding goodwill)18,740  
Other noncurrent assets1,7861,272324
Other undisclosed noncurrent assets100,000  
Total noncurrent assets:128,0594,51427,349
TOTAL ASSETS:294,651240,864146,712
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities39,88916,56212,679
Accounts payable9,1663,1513,351
Accrued liabilities30,72313,4119,328
Debt  397
Derivative instruments and hedges, liabilities1,9961,264 
Other undisclosed current liabilities711636 
Total current liabilities:42,59618,46213,076
Noncurrent Liabilities
Long-term debt and lease obligation1,9032,6273,251
Operating lease, liability1,9032,6273,251
Liabilities, other than long-term debt172936
Other liabilities172936
Other undisclosed noncurrent liabilities129,92347,651 
Total noncurrent liabilities:131,84350,3073,287
Total liabilities:174,43968,76916,363
Stockholders' equity
Stockholders' equity attributable to parent120,212172,095130,349
Common stock332
Additional paid in capital377,403345,180200,119
Accumulated other comprehensive income (loss)(35)83129
Accumulated deficit(257,159)(173,171)(69,901)
Total stockholders' equity:120,212172,095130,349
TOTAL LIABILITIES AND EQUITY:294,651240,864146,712

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
Revenues19,138  
Gross profit:19,138  
Operating expenses(192,551)(104,296)(54,743)
Operating loss:(173,413)(104,296)(54,743)
Nonoperating income (expense)(216)1,3672,211
Investment income, nonoperating3661,5592,232
Other nonoperating expense(582)(192)(21)
Loss from continuing operations before equity method investments, income taxes:(173,629)(102,929)(52,532)
Other undisclosed income (loss) from continuing operations before income taxes89,678(335) 
Loss from continuing operations before income taxes:(83,951)(103,264)(52,532)
Income tax expense(37)(6)(21)
Net loss available to common stockholders, diluted:(83,988)(103,270)(52,553)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
Net loss:(83,988)(103,270)(52,553)
Comprehensive loss:(83,988)(103,270)(52,553)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(118)(46)129
Comprehensive loss, net of tax, attributable to parent:(84,106)(103,316)(52,424)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: